Rhythm Pharmaceuticals (RYTM): Losses Have Averaged 18.8% Growth Annually; Revenue Forecast +45.8% Heading Into Earnings [Yahoo! Finance]
Rhythm Pharmaceuticals, Inc. (RYTM)
Last rhythm pharmaceuticals, inc. earnings: 3/8 08:12 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.rhythmtx.com
Company Research
Source: Yahoo! Finance
years and no period of positive net profit margin or high-quality past earnings to report. Despite the consistent losses, investors are focusing on the company's rapid revenue growth forecast of 45.8% per year and expectations for earnings to increase by 69.6% per year, with profitability anticipated within the next three years. The current share price of $99.47 sits below the fair value estimate of $173.58, and positive reward signals include rapid revenue growth, strong future earnings potential, and trading below analyst targets, keeping investor attention high while profitability remains elusive. See our full analysis for Rhythm Pharmaceuticals. Now let's see how these headline numbers compare to the widely followed narratives. Some perspectives may be confirmed, while others could be up for debate as we dig deeper. See what the community is saying about Rhythm Pharmaceuticals NasdaqGM:RYTM Earnings & Revenue History as at Nov 2025 Margins Projected to Swing from -120.6%
Show less
Read more
Impact Snapshot
Event Time:
RYTM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RYTM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RYTM alerts
High impacting Rhythm Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
RYTM
News
- Rhythm Pharmaceuticals (NASDAQ:RYTM) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.MarketBeat
- Rhythm: Maintaining Strong Buy On Acquired Hypothalamic Obesity Drug Progress [Seeking Alpha]Seeking Alpha
- Rhythm Pharmaceuticals (NASDAQ:RYTM) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.MarketBeat
- Rhythm Pharmaceuticals (NASDAQ:RYTM) had its price target raised by analysts at Canaccord Genuity Group Inc. from $105.00 to $114.00. They now have a "buy" rating on the stock.MarketBeat
- Rhythm Pharmaceuticals Announces Presentation of Four Datasets at ObesityWeek® 2025 [Yahoo! Finance]Yahoo! Finance
RYTM
Earnings
- 11/4/25 - Miss
RYTM
Sec Filings
- 11/24/25 - Form 4
- 11/20/25 - Form 144
- 11/14/25 - Form SCHEDULE
- RYTM's page on the SEC website